Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

926
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
926

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Comorbidity Clusters in Acute Heart Failure: Insights From the AMERICCAASS Registry.

Journal of the American Heart Association·2026
Same author

Characterization of 2,500 Patients with Heart Failure and Analysis of Their Optimal Medical Therapy: Insights from the AMERICCAASS Registry.

Global heart·2025
Same author

Biochemical differences based on sex and clusters of biomarkers in patients with COVID-19: analysis from the CARDIO COVID 19-20 registry.

BMC cardiovascular disorders·2025
Same author

Advancing Cardiac Care: A Registry of Heart Transplantation in Latin America (1968-2022).

Transplantation proceedings·2024
Same author

Association of Abnormal Cardiac Biomarkers and Cardiovascular Complications, with Mortality in Patients with SARS-CoV-2 Infection in Latin America.

Journal of cardiovascular development and disease·2024
Same author

American registry of ambulatory and acute decompensated heart failure (AMERICCAASS registry): Rationale and design.

ESC heart failure·2024

相关实验视频

Updated: Jun 29, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

587

[糖尿病和心力衰竭]

Walter Alarco1

  • 1Unidad de Insuficiencia Cardiaca, Trasplante Cardiaco e Hipertensión Pulmonar Instituto Nacional Cardiovascular INCOR. Lima, Perú.

Archivos peruanos de cardiologia y cirugia cardiovascular
|April 4, 2024
PubMed
概括

糖尿病 (DM) 显著增加心力衰竭 (HF) 的风险. -葡萄糖携带载体2抑制剂 (SGLT2i) 对患有高血压的糖尿病患者提供了至关重要的好处,改善了超出血糖控制的结果.

科学领域:

  • 心脏病学和内分泌学.
  • 糖尿病心肌病症 糖尿病心肌病症
  • 心脏代谢疾病研究研究.

背景情况:

  • 糖尿病是一种与心血管并发症相关的慢性疾病,包括心力衰竭 (HF).
  • HF和DM共享双向关系,HF是糖尿病患者常见的初始心血管事件.
  • 糖尿病心肌病可以通过动脉样硬化和非动脉样硬化途径引起HF,包括糖尿病心肌病.

研究的目的:

  • 探索DM和HF之间的关系.
  • 讨论糖尿病患者HF的治疗策略.
  • 突出SGLT2抑制剂在治疗患有DM的高血压炎中的作用.

主要方法:

  • 审查关于DM,HF及其治疗方式的现有文献.
  • 对DM影响心脏的机制的分析.
  • 在HF患者中评估SGLT2抑制剂的临床益处.

主要成果:

  • 不管血糖控制如何,SGLT2抑制剂在HF患者中显示出显著的临床益处.
  • 这些药物具有性作用,包括代谢,血液动力和心脏保护作用.
  • DAPA-HF研究支持SGLT2抑制剂在降低射出分数的高血压中有效.
关键词:
糖尿病 糖尿病患者 糖尿病患者心脏衰竭是因为心脏衰竭.

更多相关视频

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

175
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.5K

相关实验视频

Last Updated: Jun 29, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

587
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

175
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.5K

结论:

  • 在糖尿病患者中,SGLT2抑制剂代表了降低射出分数的高血压治疗的新时代.
  • 它们的好处超出了降低葡萄糖的范围,影响了心血管疾病和死亡率.
  • 在糖尿病人群中,可能需要对HF与保留射出分数进行进一步的研究.